Hemab Therapeutics Holdings Ownership | Who Owns Hemab Therapeutics Holdings?

Hemab Therapeutics Holdings Ownership Summary

Hemab Therapeutics Holdings is owned by 120.52% institutional investors, 10.78% insiders. Ra capital management is the largest institutional shareholder, holding 25.93% of COAG shares. American Funds SMALLCAP World A is the top mutual fund, with 7.51% of its assets in Hemab Therapeutics Holdings shares.

COAG Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Hemab Therapeutics Holdings	120.52%	10.78%	-31.30%
Sector	Healthcare Stocks	245.07%	12.10%	-157.17%
Industry	Biotech Stocks	380.48%	11.73%	-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	7.81M	25.93%	$286.81M
Novo	4.18M	13.88%	$153.55M
Fmr	3.70M	12.28%	$135.82M
Capital investors	3.60M	11.97%	$132.37M
Deep track capital, lp	3.60M	11.96%	$132.30M
Siren	2.09M	6.93%	$76.65M
Avoro capital advisors	1.93M	6.39%	$70.71M
Bain capital life sciences investors	1.65M	5.48%	$60.60M
Jpmorgan chase	1.15M	3.83%	$42.33M
Vanguard capital management	780.76K	2.59%	$28.68M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Novo	4.18M	8.92%	$153.55M
Bain capital life sciences investors	1.65M	3.60%	$60.60M
Ra capital management	7.81M	2.49%	$286.81M
Deep track capital, lp	3.60M	1.93%	$132.30M
Siren	2.09M	1.55%	$76.65M
Rock springs capital management lp	575.43K	1.03%	$21.14M
Avoro capital advisors	1.93M	0.64%	$70.71M
Bellevue group	550.00K	0.43%	$20.20M
Affinity asset advisors	138.03K	0.23%	$5.07M
Braidwell lp	160.00K	0.22%	$5.88M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	7.81M	2.49%	7.81M
Novo	4.18M	8.92%	4.18M
Fmr	3.70M	0.01%	3.70M
Capital investors	3.60M	0.03%	3.60M
Deep track capital, lp	3.60M	1.93%	3.60M

Top Sellers

Holder	Shares	% Assets	Change
Tower research capital llc (trc)	1.00	-	1.00
Jones financial companies lllp	3.00	-	3.00
Royal bank of canada	248.00	-	248.00
Barclays	1.01K	-	1.01K
Citigroup	2.10K	-	2.10K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	7.81M	2.49%	7.81M	$286.81M
Novo	4.18M	8.92%	4.18M	$153.55M
Fmr	3.70M	0.01%	3.70M	$135.82M
Capital investors	3.60M	0.03%	3.60M	$132.37M
Deep track capital, lp	3.60M	1.93%	3.60M	$132.30M

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	56	-	36,291,239	-	120	-	56	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds SMALLCAP World A	3.51M	7.51%	3.51M
Fidelity Growth Compy Commingled Pl S	691.58K	1.48%	-
Vanguard Morn Total Stk Mkt Idx Investor	555.54K	1.19%	523.56K
Vanguard MStar Total Stk Mkt Idx Invest	555.54K	1.19%	-
JPMorgan Small Cap Growth A	531.38K	1.14%	-
State Street® SPDR® S&P® Biotech ETF	528.12K	1.13%	5.94K
Fidelity Growth Company Fund	523.85K	1.12%	-
iShares Russell 2000 ETF	512.62K	1.10%	4.37K
Fidelity Stock Selector Small Cap	439.95K	0.94%	71.65K
Fidelity Select Biotechnology	439.48K	0.94%	-

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-

COAG Ownership FAQ

Who Owns Hemab Therapeutics Holdings?

Hemab Therapeutics Holdings shareholders are primarily institutional investors at 120.52%, followed by 10.78% insiders and -31.30% retail investors. The average institutional ownership in Hemab Therapeutics Holdings's industry, Biotech Stocks , is 380.48%, which Hemab Therapeutics Holdings falls below.

Who owns the most shares of Hemab Therapeutics Holdings?

Hemab Therapeutics Holdings’s largest shareholders are Ra capital management (7.81M shares, 25.93%), Novo (4.18M shares, 13.88%), and Fmr (3.7M shares, 12.28%). Together, they hold 52.10% of Hemab Therapeutics Holdings’s total shares outstanding.

Does Blackrock own Hemab Therapeutics Holdings?

BlackRock is not among the top 10 institutional shareholders of Hemab Therapeutics Holdings.

Who is Hemab Therapeutics Holdings’s biggest shareholder by percentage of total assets invested?

Novo is Hemab Therapeutics Holdings’s biggest shareholder by percentage of total assets invested, with 8.92% of its assets in 4.18M Hemab Therapeutics Holdings shares, valued at 153.55M$.

Who is the top mutual fund holder of Hemab Therapeutics Holdings shares?

American Funds SMALLCAP World A is the top mutual fund holder of Hemab Therapeutics Holdings shares, with 7.51% of its total shares outstanding invested in 3.51M Hemab Therapeutics Holdings shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools